COMMUNIQUÉS West-GlobeNewswire

Tetraphase Pharmaceuticals Announces FDA Approval of XERAVA™ (Eravacycline) for Complicated Intra-Abdominal Infections (cIAI)
27/08/2018
– XERAVA™ Achieved High Clinical Cure Rates in Clinical Trials in Patients with cIAI – – Broad Product Label for Treatment of cIAI – – Commercial Launch Expected in the Fourth Quarter of 2018 – – Conference Call [...]
XBiotech annonce la publication de résultats décisifs sur le rôle potentiel de l'Interleukine-1 alpha dans le risque des crises cardiaques
27/08/2018
Les résultats montrent la capacité de MABp1 (Bermekimab) à bloquer l'activation endothéliale vasculaire par neutrophile in vitro et la thrombose AUSTIN, Texas, 27 août 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: [...]
Affimed Announces Collaboration with Genentech to Develop Novel NK Cell Engager-based Immunotherapeutics for Multiple Cancer Targets
27/08/2018
Affimed will receive $96 million upfront and committed funding and is eligible for up to an additional $5.0 billion including milestone payments, and royalties on sales Heidelberg, Germany, August 27, 2018 - Affimed N.V [...]
Alphatec to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
27/08/2018
CARLSBAD, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through [...]
K2M Group Holdings, Inc. to Participate in Two Investor Conferences in September
27/08/2018
LEESBURG, Va., Aug. 27, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional [...]
Editas Medicine Announces Transition of Chief Medical Officer
27/08/2018
CAMBRIDGE, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT), a leading genome editing company, today announced that its Chief Medical Officer, Gerald Cox, M.D., Ph.D., will be stepping down [...]
Wright Medical Group N.V. Announces Proposed Public Offering of Ordinary Shares
27/08/2018
Offering of $440 Million Ordinary Shares AMSTERDAM, The Netherlands, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ:WMGI) today announced the commencement of a registered underwritten public [...]
Ultragenyx Announces Approval of Mepsevii™ (vestronidase alfa) in Europe for the Treatment of Mucopolysaccharidosis VII
27/08/2018
Mepsevii, an Enzyme Replacement Therapy, is the First Treatment Approved in the EU for Mucopolysaccharidosis VII NOVATO, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a [...]
National Brain Tumor Society Statement on Passing of Sen. John McCain
27/08/2018
Boston, MA , Aug. 27, 2018 (GLOBE NEWSWIRE) -- National Brain Tumor Society is profoundly saddened to learn of the senator’s passing, and our thoughts immediately go out to his family, friends, staff, colleagues and [...]
La Costa Glen Retirement Community Named Great Place to Work
27/08/2018
CARLSBAD, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- The La Costa Glen continuing care retirement community in Carlsbad, California, has been certified as a top workplace by the independent research and consulting firm [...]
Biosenta Announces Signing Exclusive Global Royalty Agreement
27/08/2018
TORONTO, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Biosenta Inc. (CSE: ZRO) is pleased to announce, in conjunction with Microbial Research Products, the Joint Venture (JV) Agreement announced on February 28, 2018, it has signed [...]
Cognoa Demonstrates Advances of its AI-Based Technology for Identifying Autism in Children
27/08/2018
Two clinical studies published in peer-reviewed journals validate continued accuracy improvements of the company’s artificial intelligence (AI) platform PALO ALTO, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Cognoa, a [...]
NeuroMetrix to Present at H.C.Wainwright & Co 20th Annual Global Investment Conference in New York City
27/08/2018
Presentation Shifted to 10:00 am on September 6, 2018 WALTHAM, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) reported that the time previously announced for its presentation at the H.C. [...]
DBV Technologies: Monthly information regarding the total number of voting rights and total number of shares of the Company
27/08/2018
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]
DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social
27/08/2018
Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]
Vitalhub Reports Second Straight Quarter of Positive Adjusted EBITDA
27/08/2018
TORONTO, Aug. 27, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV:VHI) announced today it has filed its Interim Condensed Consolidated Financial Statements and Management's Discussion and [...]
Landmarks Around the World to “Go Teal” on November 8th for AFA’s “Light the World in Teal” Alzheimer’s Awareness Campaign
27/08/2018
One World Trade Center, Madison Square Garden, LAX Airport, Country Music Hall of Fame and Wrigley Building Among the Approximately 200 Landmarks “Going Teal” to Raise Alzheimer’s Awareness NEW YORK, Aug. 27, 2018 ( [...]
Adamis Pharmaceuticals Provides Business Update
27/08/2018
SAN DIEGO, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today provided a business update. Dr. Dennis J. Carlo, President and Chief Executive Officer of Adamis Pharmaceuticals, said [...]
Ossur Hf : Transactions in relation to share buyback program
27/08/2018
Announcement no. 52/2018 27 August 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the share [...]

Pages